The Latin America In Vitro Fertilization Market was valued at $60.3 Million in 2024 and projected to reach to $96.4 Million by 2029, representing a compound annual growth rate of 9.8%. Latin America's IVF market is positioned for sustained growth driven by demographic shifts, economic development, and increasing healthcare accessibility.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America's IVF market is valued at $60.3 million in 2024, with a projected CAGR of 9.8% through 2029, reaching $96.4 million. This growth outpaces many developed regions, reflecting strong regional demand for assisted reproductive technologies.
Increasing infertility rates across Latin America are driving demand for IVF treatments. Growing public awareness campaigns and improved access to reproductive health information are encouraging couples to seek assisted reproductive solutions.
Rising disposable incomes in major Latin American economies are enabling more families to afford IVF treatments. Economic growth in countries like Brazil and Mexico is expanding the patient base capable of accessing fertility services.
Expanding fertility clinics and improved healthcare infrastructure across Latin America are making IVF treatments more accessible. Investment in reproductive medicine facilities is strengthening the region's capacity to serve growing patient demand.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | FROZEN NON-DONORS (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.7% from 2024 to 2029 |
| Largest Segment | EQUIPMENT (Product) |
| Market Size Base Year (Billions) | ~USD 0.95 (2024) |
| Revenue Forecast (Billions) | ~USD 1.65 (2029) |
| Segments Covered | Product, Type, Type Of Cycle, Procedure, End User |
5 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 56.7 Million |
| Mexico | USD 18.1 Million |
| Rest Of Latin America | USD 21.5 Million |
The In Vitro Fertilization market in Latin America was valued at $60.3 million in 2024 and is projected to reach $96.4 million by 2029.
Latin America's IVF market is growing at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Latin America's IVF market growth is driven by increasing infertility rates, rising disposable incomes, improved healthcare infrastructure, delayed childbearing trends, and expanding insurance coverage for fertility treatments.
Latin America's IVF market is growing at 9.8% CAGR, slightly below the global average of 11.7%, but represents a significant regional opportunity with strong fundamentals and expanding access to fertility services.
Latin America's competitive pricing for IVF procedures relative to developed markets attracts international patients seeking fertility treatments, contributing to regional market growth and clinic utilization rates.
In this research, the utilization of both primary and secondary sources was done to a great extent. This included studying the factors affecting the industry to find out the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and strategies by key players.
The secondary research process involves methods using directories, databases such as D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings, and collation of the database of industry leaders. This would help in fleshing out basic information on key players and market segmentation based upon the trends of the industry at various levels, major developments in the market, and technological perspectives pertaining to the in vitro fertilization market.
Primary research for this report featured interviews with a cross-section of sources from both the supply and demand sides to generate qualitative and quantitative data. On the supply side, there were primary sources from industries represented by CEOs, vice presidents, marketing and sales directors, regional sales managers, technology and innovation directors, and other key executives from leading companies and organizations in product therapy markets. Primary sources on the demand side included but were not limited to: embryologists, clinicians, procurement managers, purchase managers, department heads, and professionals from hospitals, fertility clinics, in vitro fertilization centers, and reference labs, among others. This primary research was hoped to validate market segmentation, identify key market players, and get an overview of the key trends and dynamics of the industry.

To know about the assumptions considered for the study, download the pdf brochure
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
This report also presents the key players' revenue share analysis for the size of the in vitro fertilization market. The identification of key market participants and insights about their revenues in the in vitro fertilization sector are gathered through phases of primary and secondary research. The secondary research process relied heavily on top players' annual and financial reports, while primary research involved highly exhaustive interviews with key opinion leaders, viz., CEOs, directors, and senior marketing executives.
The methodology adopted to calculate the global market value was on a segment basis. These segmental revenues were then sourced through the revenue data of major solution and service providers. The steps involved in the process are

To know about the assumptions considered for the study, Request for Free Sample Report


The in vitro fertilization market was segmented under various categories and subcategories using the above-mentioned methodology. Thereafter, proper data triangulation and the market segmentation process are carried out to further increase the accuracy of the data for each segment. Factors and trends from both the demand and supply sides were studied. Rigorous employment of both top-down and bottom-up approaches provided the result of the analysis of the in vitro fertilization market.
The in vitro fertilization market refers to the global landscape of Assisted Reproductive Technologies services and products that help a person or a couple conceive. It is a market that represents fertility clinics, hospitals, and even research institutions that provide in vitro fertilization treatments and related services, including medical devices, laboratory equipment, drugs, and consumables used for in vitro fertilization procedures. It also includes the diagnostic tests carried out prior to and in the course of in vitro fertilization, genetic screening technologies, and cryopreservation services. In vitro fertilization market has been used as a generic term describing the portfolio of diverse technologies, services, and products relating to the alleviation of infertility and the promotion of reproductive health.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global In vitro fertilization market
Full forecast, segment splits, and company analysis for all In Vitro Fertilization Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report